Prestige Consumer Healthcare Inc
NYSE:PBH
Prestige Consumer Healthcare Inc
NYSE:PBH
Price:
70.39 USD
0.1%
Market Closed
Updated:
May 13, 2024
Prestige Consumer Healthcare Inc
Other Current Liabilities
|
Prestige Consumer Healthcare Inc
Other Current Liabilities Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Prestige Consumer Healthcare Inc
NYSE:PBH
|
Other Current Liabilities
$6m
|
CAGR 3-Years
171%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Other Current Liabilities
$3.3B
|
CAGR 3-Years
21%
|
CAGR 5-Years
17%
|
CAGR 10-Years
14%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Other Current Liabilities
$6.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
32%
|
CAGR 10-Years
13%
|
|
|
Pfizer Inc
NYSE:PFE
|
Other Current Liabilities
$28B
|
CAGR 3-Years
20%
|
CAGR 5-Years
15%
|
CAGR 10-Years
10%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Other Current Liabilities
$5.4B
|
CAGR 3-Years
19%
|
CAGR 5-Years
17%
|
CAGR 10-Years
7%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Other Current Liabilities
$4.2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
9%
|
CAGR 10-Years
3%
|
See Also
What is Prestige Consumer Healthcare Inc's Other Current Liabilities?
Other Current Liabilities
6m
USD
6m
USD
Based on the financial report for Dec 31, 2023, Prestige Consumer Healthcare Inc's Other Current Liabilities amounts to 6m USD.
What is Prestige Consumer Healthcare Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
-1%
-1%
Over the last year, the Other Current Liabilities growth was -15%. The average annual Other Current Liabilities growth rates for Prestige Consumer Healthcare Inc have been 171% over the past three years , -1% over the past five years .
You don't have any saved screeners yet
